Bevacizumab
Formulations: - Parenteral > Locoregional injections > Intravitreal: 25 mg per mL Indications: - Age related macular degeneration Source: EML workbook import
MOQ: 1
Price on request
Imported from EML workbook.
Formulations: - Parenteral > Locoregional injections > Intravitreal: 25 mg per mL Indications: - Age related macular degeneration Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.